CIK 0001622229
- Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465308248
- Phone
- +1 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-19 | Robbins Andrew R President and CEO | Gift | −160,000 | 497,503 | ||
| 2026-05-19 | Robbins Andrew R President and CEO | Gift | +160,000 | 160,000 | ||
| 2025-12-17 | Robbins Andrew R President and CEO | Grant or award | +185,000 | 185,000 | ||
| 2025-12-17 | Robbins Andrew R President and CEO | Grant or award | +840,000 | 1,025,000 | ||
| 2025-12-17 | Robbins Andrew R President and CEO | Shares withheld for taxes | −367,497 | $39.45 | $14.5M | 657,503 |
| 2025-12-17 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +245,000 | 245,000 | ||
| 2025-01-23 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +915,000 | 915,000 | ||
| 2024-01-23 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +1,100,000 | 1,100,000 | ||
| 2023-02-13 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +525,000 | 525,000 | ||
| 2022-01-25 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +690,000 | $4.94 | $3.4M | 690,000 |
| 2021-02-10 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +315,200 | 315,200 | ||
| 2020-12-07 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +456,693 | 456,693 | ||
| 2020-10-23 | Robbins Andrew R President and CEO | Grant or award · Stock Option (Right to Buy) | +7,442,421 | 7,442,421 |
Page 1 of 1 · 13 trades